I assume that CLV is a DHA supplier for A2M / SM1 but not 100% sure. Certainly they supply a lot of Aus/NZ companies exporting to China and are similarly exposed.
CLV update today shows the GB license update process has definitely disrupted normal demand patterns across the industry. Not necessarily a reduction but rather sales being pushed back into FY24 due to the hiatus in production. My interpretation anyway.
PS. Worth noting that the update above seemed to have been received somewhat positively by the ASX
I assume that CLV is a DHA supplier for A2M / SM1 but not 100%...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$8.09 |
Change
0.060(0.75%) |
Mkt cap ! $5.857B | |||
| Open | High | Low | Value | Volume |
| $8.05 | $8.11 | $8.02 | $12.16M | 1.507M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 985 | $8.09 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $8.10 | 1768 | 2 |
View Market Depth
| Last trade - 16.10pm 31/07/2025 (20 minute delay) ? |
| A2M (ASX) Chart |